Home » GENELABS GETS $1.25 MILLION PAYMENT
GENELABS GETS $1.25 MILLION PAYMENT
Genelabs Technologies has received a $1.25 million license payment from Affymetrix. The money is part of an amendment to a license agreement between the two companies for Genelabs' DNA amplification technology, used in drug discovery.
San Francisco Business Times (http://www.bizjournals.com/sanfrancisco/stories/2004/12/27/daily29.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct